- Rising to the challenge of malaria eradication
- Chinese startup CareVoice closes series A round
- The Asia Pacific cardiovascular devices market to reach $16,107.3 Mn in 2027
- Fitbit collaborates with Singapore’s Health Promotion Board
- CStone registers for Phase I trial of CDK4/6 inhibitor CS3002 in Australia
- Gencurix's study explores GenesWell BCT and Oncotype DX differences
- Merck, Thermis collaborate to develop vaccines
- Biocon Malaysia unit receives EU GMP certification
- China approves AstraZeneca drug to treat anaemia in CKD patients
- Voronoi selects CDD Vault platform to manage Drug Discovery Data
- Australia's Propanc Biopharma gets US Patent
- GSK submits first regulatory application for daprodustat in Japan
- Luye Pharma's anti-depression drug to start clinical trials in Japan
- Boston Scientific announces FDA approval Of ImageReady MRI
-
Singapore | 09 July 2019 | News
Asia HealthTech momentum continues unabated closing H1 2019 at $2.5B
Galen Growth Asia, the leading exclusive HealthTech research, analytics and advisory firm in Asia Pac (Asia) s...Read more
Singapore | 04 July 2019 | News
Latest technologies to transform healthcare
A new consortium led by the Institute for Health Innovation and Technology (iHealthtech) at NUS will tap on th...Read more
-
World | 23 August 2019 | News
Merck, Thermis collaborate to develop vaccines
Themis Bioscience has announced a research collaboration and exclusive license agreement with MSD (t...Read more
-
Malaysia | 23 August 2019 | News
Biocon Malaysia unit receives EU GMP certification
Biocon Ltd , Asia’s premier biopharmaceuticals company, Biocon Ltd has announced that it’s subsidi...Read more
-
Middle East countries | 16 July 2019 | News
Filterlex Medical raises $3M in Series A Financing
Filterlex Medical is a medical device start-up company based in Israel, developing an innovative embolic ...Read more
-
Thailand | 30 July 2019 | News
Thai startups to capture a major chunk of healthcare market
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs wan...Read more
Stem cells gaining importance
Stem cell research stands as a high-priority field in the Asia-Pacific (APAC) and investment in these facilities are growing in order to increase competitiveness in the free market so that clinical applications can be continually discovered. Stringent regulations in Western Europe and the USA in stem cell therapy and regenerative medicine have driven the APAC to grow at the highest rate in this industry. Stem cell therapy is a hot topic in the field of medicine and is growing at a fast pace, BioSpectrum takes a look at how this exciting field is faring in the APAC region.
